Framingham, MA, United States of America

Alzheon, Inc.

Calculating rank
USPTO Granted Patents = 10


Forward Citations = 10

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Martin Tolar (10 out of 10 patents)

silverMedal John A Hey (10 out of 15 patents)

bronzeMedal Petr Kocis (9 out of 9 patents)

4.  Susan Abushakra (2 out of 2 patents)

5.  Jeremy Yu (2 out of 2 patents)

6.  Aidan Power (1 out of 1 patent)

7.  Neil William Flanzraich (1 out of 1 patent)

8.  John Hey (0 patent)


10 patents:

Company Overview
Alzheon, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative medicines for patients suffering from neurodegenerative diseases, including Alzheimer's disease. The company's lead product candidate, ALZ-801, is in development as a potential treatment for early and mild Alzheimer's disease. Alzheon's mission is to deliver new treatment options that target the underlying pathology of neurodegenerative diseases to improve the lives of patients and their families.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

10 Patents

#25 in Framingham, MA

#1,780 in Massachusetts

#29,966 in US

#56,291 in the World

Framingham, MA (US)
Framingham, MA, United States of America
Forward Citations = 10

8 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alzheon, Inc.. Retrieved from https://idiyas.com/company/alzheon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…